ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹269 Cr | ₹52 Cr | ₹107 Cr | ₹-86 Cr | ₹73 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ABBOTT INDIA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹-86 Cr |
| Mar2021 | ₹73 Cr |
How is Net Cash Inflow / Outflow of ABBOTT INDIA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹269 Cr | 416.32 | |
| Mar2024 | ₹52 Cr | -51.32 | |
| Mar2023 | ₹107 Cr | Positive | |
| Mar2022 | ₹-86 Cr | Negative | |
| Mar2021 | ₹73 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹55,754.5 Cr | -5.1% | 3.4% | -12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,349.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,543.0 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,884.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,077.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,388.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -5.1% |
3.4% |
-12.8% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses